KAKEN PHARMACEUTIAL CO., LTD.
R&D pharma firm creating drugs & devices for orthopedics, dermatology, and surgery globally.
4521 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 文京区本駒込二丁目２８番８号
- Website:
- https://www.kaken.co.jp/english/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kaken Pharmaceutical Co., Ltd. is an R&D-driven pharmaceutical company engaged in the research, development, manufacturing, and marketing of prescription drugs, medical devices, and agrochemicals. The company focuses on creating innovative treatments, particularly in the fields of orthopedics, dermatology, and surgery. Its main products include Artz, an anti-osteoarthritis agent, and Clenafin, a treatment for onychomycosis. Kaken Pharmaceutical also has operations in animal health and real estate. With a corporate philosophy centered on improving patients' quality of life, the company distributes its products both in Japan and internationally.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for KAKEN PHARMACEUTIAL CO., LTD. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-09 07:12 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.2 KB | |
| 2025-08-06 08:52 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.2 KB | |
| 2025-07-09 08:16 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.9 KB | |
| 2025-07-01 02:34 |
Regulatory News Service
臨時報告書
|
Japanese | 28.2 KB | |
| 2025-06-26 03:41 |
Regulatory News Service
内部統制報告書－第105期(2024/04/01－2025/03/31)
|
Japanese | 24.6 KB | |
| 2025-06-26 03:39 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-06-26 03:38 |
Annual Report
有価証券報告書－第105期(2024/04/01－2025/03/31)
|
Japanese | 1.8 MB | |
| 2025-06-11 06:41 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.7 KB | |
| 2025-05-30 08:42 |
Regulatory News Service
臨時報告書
|
Japanese | 84.4 KB | |
| 2025-05-14 05:01 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.3 KB | |
| 2025-04-10 04:16 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 26.5 KB | |
| 2025-03-12 02:56 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.1 KB | |
| 2024-12-26 07:35 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 82.4 KB | |
| 2024-11-13 05:25 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-11-13 05:24 |
Interim Report
半期報告書－第105期(2024/04/01－2025/03/31)
|
Japanese | 243.3 KB |
Automate Your Workflow. Get a real-time feed of all KAKEN PHARMACEUTIAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for KAKEN PHARMACEUTIAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
